Melatonin, which is a major neurohormone that increases sleepiness, and decreases cutaneous inflammatory markers associated with AD, such as IL-4 and IgE, is decreased in AD patients during periods of exacerbation [4,36]. Here, IL4 is linked to Alzheimer disease.